Scotiabank analyst Louise Chen initiated coverage with a Buy rating on AbbVie (ABBV – Research Report) yesterday and set a price target of ...

Cantor Fitzgerald analyst Carter Gould initiated coverage of AbbVie (ABBV) with an Overweight rating and $210 price target AbbVie offers a ...

Joey Jordison ’s family have shared the drummer’s original design of the Slipknot logo.

DelveInsight's "XADAGO/EQUFINA Market Size, Forecast, and Market Insight Report" highlights the details around XADAGO/EQUFINA ...

BCC Research reveals in its new report, Alzheimer's Disease Therapeutics and Diagnostics: Global Markets, the market for ...

Shares of AbbVie Inc. ABBV advanced 1.88% to $177.05 Wednesday, on what proved to be an all-around positive trading session ...

AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7 billion to buy central nervous system drug specialist Cerevel Therapeutics, which spun out of Pfizer ...

"Emerging blood-based diagnostics and disease-modifying therapeutics set to revolutionize Alzheimer's disease market, addressing public health crisis and economic burden." BOSTON, April ...

Johnson & Johnson’s Kenvue – previously the planned New Consumer Health Company – is just one part of the 135-year old company’s plan to reinvigorate its corporate image. The name "Kenvue ...

Apr 20, 2025 Apr 20, 2025 Updated 44 mins ago 0 ...